Press Releases

Press Releases

Date Title and Summary Additional Formats
Toggle Summary Predictive Oncology Inc. Appoints Dan Handley, M.S., Ph.D. to Board of Directors
MINNEAPOLIS , Feb. 21, 2020 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive Oncology” or “the Company”), a data and artificial intelligence (“AI”) driven discovery services company that provides predictive models of tumor drug response to improve clinical outcomes for
View HTML
Toggle Summary Predictive Oncology Launches Innovative Specialty Media for Growing Ovarian Tumors in the Lab
New Formulations Will Speed Discovery of Biomarkers and Precision Therapies MINNEAPOLIS , Feb. 05, 2020 (GLOBE NEWSWIRE) -- TumorGenesis, Inc. a subsidiary of Predictive Oncology, Inc. (NASDAQ: POAI) has selected US Biological Corporation of Salem, Massachusetts as the manufacturer and distributor
View HTML
Toggle Summary Predictive Oncology Inc. Signs Letter of Intent to Acquire Quantitative Medicine (qtmed.com) and an AI Engine™ (CoRE™) that Facilitates Accelerated Drug Discovery and Development
AI platform was developed at the Ray and Stephanie Lane Center for Computational Biology, which became the Computational Biology Department at Carnegie Mellon University and was successfully tested by several pharma companies MINNEAPOLIS , Jan. 24, 2020 (GLOBE NEWSWIRE) -- Predictive Oncology Inc.
View HTML
Toggle Summary Predictive Oncology Inc. Appoints Pam Prior to Board of Directors
MINNEAPOLIS , Jan. 06, 2020 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive Oncology” or “the Company”), a data and artificial intelligence (“AI”) driven discovery services company that provides predictive models of tumor drug response to improve clinical outcomes for
View HTML
Toggle Summary Predictive Oncology Inc. Announces Extension Of Promissory Note Due December 31, 2019
MINNEAPOLIS , Dec. 17, 2019 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive Oncology” or “the Company”), a data and artificial intelligence (“AI”) driven discovery services company that provides predictive models of tumor drug response to improve clinical outcomes for
View HTML
Toggle Summary Predictive Oncology Provides Updates on Commercialization of Its Cancer Quest 2020 Initiative
MINNEAPOLIS , Dec. 09, 2019 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive Oncology” or “the Company”), a data and artificial intelligence (“AI”) driven discovery services company that provides predictive models of tumor drug response to improve clinical outcomes for
View HTML
Toggle Summary Predictive Oncology Confirms Indications of Interest for Skyline Medical Business
MINNEAPOLIS , Dec. 05, 2019 (GLOBE NEWSWIRE) -- Predictive Oncology Inc.  (NASDAQ: POAI) (“Predictive Oncology” or “the Company”), focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, today announced that it has received indications of interest from
View HTML
Toggle Summary Predictive Oncology Has Regained Compliance with Nasdaq’s Minimum Bid Price Requirement
MINNEAPOLIS , Nov. 25, 2019 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive Oncology” or “the Company”), focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, today announced that based on a notification letter (the “Notification
View HTML
Toggle Summary Predictive Oncology Secures $15,000,000 Equity Line
MINNEAPOLIS , Nov. 20, 2019 (GLOBE NEWSWIRE) -- Predictive Oncology Inc.  (NASDAQ: POAI) (“Predictive Oncology” or “the Company”), focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, today announced that it entered into a $15 million common stock purchase
View HTML
Toggle Summary Predictive Oncology CEO Discusses Corporate Milestones, Unique Approach to Cancer Research in Exclusive Broadcast
NEW YORK , Nov. 19, 2019 (GLOBE NEWSWIRE) -- via NetworkNewsAudio – Predictive Oncology Inc. (NASDAQ: POAI), a knowledge-driven precision medicine company focused on applying data and artificial intelligence (AI) to personalized medicine and drug discovery, today announces the broadcast of its
View HTML